Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

Hierarchical Bayes Model for Predicting Effectiveness of HIV Combination Therapies

MPG-Autoren
/persons/resource/persons44156

Bogojeska,  Jasmina
Computational Biology and Applied Algorithmics, MPI for Informatics, Max Planck Society;

/persons/resource/persons44907

Lengauer,  Thomas
Computational Biology and Applied Algorithmics, MPI for Informatics, Max Planck Society;

Externe Ressourcen
Es sind keine externen Ressourcen hinterlegt
Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Bogojeska, J., & Lengauer, T. (2012). Hierarchical Bayes Model for Predicting Effectiveness of HIV Combination Therapies. Statistical Applications in Genetics and Molecular Biology, 11(3): 11, pp. 1-19. doi:10.1515/1544-6115.1769.


Zitierlink: https://hdl.handle.net/11858/00-001M-0000-0014-C580-C
Zusammenfassung
HIV patients are treated by administration of combinations of antiretroviral drugs. The very large number of such combinations makes the manual search for an effective therapy practically impossible, especially in advanced stages of the disease. Therapy selection can be supported by statistical methods that predict the outcomes of candidate therapies. However, these methods are based on clinical data sets that have highly unbalanced therapy representation.This paper presents a novel approach that considers each drug belonging to a target combination therapy as a separate task in a multi-task hierarchical Bayes setting. The drug-specific models take into account information on all therapies containing the drug, not just the target therapy. In this way, we can circumvent the problem of data sparseness pertaining to some target therapies.The computational validation shows that compared to the most commonly used approach that provides therapy information in the form of input features, our model has significantly higher predictive power for therapies with very few training samples and is at least as powerful for abundant therapies.